United Therapeutics (UTHR)
Builds pulmonary-hypertension medicines and investigational organ-manufacturing platforms.
$497.59
After hours−0.06 (−0.01%)
At close$497.65(+0.92%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 97.91% | 41.99M shares | |
|---|---|---|---|
| 901 holders · as of Jun 30, 2026 | |||
| Insiders | 7.77% | 3.33M shares | |
| 14 holders · as of Sep 22, 2026 | |||
| Adds to | 105.68% | ||
42.89M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 105.68%; nothing is left for Other.
13F, as of Jun 30, 2026
901 holders · 41.99M shares · 105 new positions · 424 increased · 336 reduced · 81 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.29M | 12.34% | −105.1K | Aug 7, 2026 |
| Avoro Capital Advisors LLC | 2.78M | 6.48% | +147.8K | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 1.92M | 4.48% | −84.3K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 1.92M | 4.47% | −39.3K | Aug 13, 2026 |
| State Street Corp | 1.90M | 4.43% | +54.1K | Aug 7, 2026 |
| Renaissance Technologies LLC | 1.71M | 3.98% | −78.3K | Aug 13, 2026 |
| Wellington Management Group LLP | 1.38M | 3.22% | −885.2K | Aug 14, 2026 |
| Geode Capital Management, LLC | 996.6K | 2.32% | −236.4K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Wellington Management Group LLP | 5.70% | 2.44M | 13G | Feb 10, 2026 |
| Vanguard Capital Management | 5.19% | 2.28M | 13G | Apr 30, 2026 |
| State Street Corporation | 5.00% | 2.24M | Oct 16, 2024 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 21, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 5 lots | 9,500 | $494.55 | 324,443 |
| Sep 18, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 6 lots | 9,500 | $494.79 | 324,443 |
| Sep 17, 2026 | Paul A. Mahonofficer: EVP & GENERAL COUNSEL | Sale · 7 lots | 8,300 | $497.54 | 45,172 |
| Sep 17, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 9 lots | 9,500 | $496.06 | 324,443 |
| Sep 16, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 8 lots | 9,500 | $501.39 | 324,443 |
| Sep 15, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 6 lots | 9,500 | $501.59 | 324,443 |
| Sep 14, 2026 | Nilda Mesadirector | Sale · 2 lots | 228 | $505.87 | 5,580 |
| Sep 14, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 5 lots | 9,500 | $504.12 | 324,443 |
| Sep 11, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 12 lots | 9,500 | $500.82 | 324,443 |
| Sep 10, 2026 | Martine A. Rothblattdirector, officer: Chairperson & CEO | Sale · 10 lots | 9,500 | $502.35 | 324,443 |
House and Senate disclosures
Not reported.